Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Down again
View:
Post by Trogarzon on Sep 09, 2022 12:15pm

Down again

Down again... maybe they put out a PR at 4:30 on a friday... we are happy to announce at bought deal with Cannaccord as the lead.... thus the 3$ target bump.... just speculating lol... but still possible... before any Th1902 news and top it off with some additional insider selling.. who knows with them... they do have a tendency to scr w-up in every way possible in the past.
Comment by Lee430 on Sep 09, 2022 12:47pm
Question, to prevent the potential ugly sell off of expiring stock grant's is it possible for the BOD to simply extend the expiration date or re issue them with a later date?
Comment by Wino115 on Sep 09, 2022 1:28pm
You could, but it could be taken as a negative too ... I.e., why didnt inside officers want to gain more exposure and instead pushed the date off? Also, adding time to any option is a value transfer to the holder worth something, using the Black Scholes formula. The simple answer is these managers work for the company and should want to own shares to incentivize them to grow its value. They knew ...more  
Comment by Trogarzon on Sep 09, 2022 1:41pm
Unthinkable for them to sell atm... specially Christian... that would be the end of the story for me.
Comment by qwerty22 on Sep 09, 2022 2:05pm
I don't disagree with this but it hasn't happened (yet).  
Comment by scarlet1967 on Sep 09, 2022 3:24pm
Below is what the MSL is suggesting in order to reach out to the stakeholders. So this was what I was exactly suggesting using the hybrid technology conveniently expanding the range and much more cost/time effective. The same logic would work when it comes to selling the company to the investors. Behind closed doors meeting with individual investors should be an add on to the whole investor ...more  
Comment by scarlet1967 on Sep 09, 2022 3:27pm
https://www.impetusdigital.com/2022/08/25/engaging-kols-gaining-insights-in-pharmas-new-normal/
Comment by qwerty22 on Sep 09, 2022 2:02pm
I remember one time being told quietly by my CFO that I just couldn't sell my options at a certain point in time. No more questions. I was only a lowly scientist, maybe the egos of execs won't take that sort of instruction but they should know better the reasons for not selling than I did at that time. It's a big assumption at present that there will be a large unloading of options. ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities